Stock S3F SANTHERA PHARMACEUTICALS HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages Santhera Pharmaceuticals Holding AG Xetra

Equities

S3F

CH0027148649

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Santhera Secures CHF69 Million Financing for Bond Repayment, Cash Runway Extension
Santhera dans les chiffres noirs en 2023
Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows
Santhera dank Catalyst-Deal mit gutem Finanzpuffer - ab 2026 Break-Even geplant
Santhera Pharmaceuticals Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023
Santhera Pharmaceuticals Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023
Spexis: sursis concordataire prolongé de 4 mois après réception d'un paiement
Santhera obtient un statut d'examen prioritaire en Chine pour le vamorolone
Santhera Pharmaceuticals Wins Priority Review for Duchenne Muscular Dystrophy Drug in China
Santhera kommt mit möglicher Zulassung von Vamorolon in China entscheidend voran
Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Grants Priority Review by China's NMPA
Santhera-Partner Catalyst Pharmaceuticals lanciert Agamree in den USA
Santhera: lancement de l'Agamree contre la myopathie de Duchenne aux USA
Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical?s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology
Aktien Schweiz auf Erholungskurs
Santhera's New Study Shows Efficacy, Safety Data for Duchenne Muscular Dystrophy Treatment
Santhera veröffentlicht Daten über Vamorolon in Fachjournal 'Neurology'
Santhera lanciert DMD-Mittel Agamree zuerst in Deutschland - weltweite Premiere
Santhera lance Agamree contre la myopathie en commençant par l'Allemagne
Santhera Pharmaceuticals Holding AG Launches AGAMREE in Germany as First Market for the Treatment of Duchenne Muscular Dystrophy
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SANN Stock
  4. S3F Stock
  5. News Santhera Pharmaceuticals Holding AG
  6. Other languages